The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics

被引：97

作者：

Andersen, Jan Terje ^{[1
]}

Sandlie, Inger

机构：

[1] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway

来源：

DRUG METABOLISM AND PHARMACOKINETICS | 2009年 / 24卷 / 04期

关键词：

neonatal Fc receptor (FcRn); IgG; albumin; half-life; pH dependent; recycling; albumin targeting; genetic fusion; HUMAN SERUM-ALBUMIN; BLOOD-BRAIN-BARRIER; IMMUNOGLOBULIN-G; FUSION PROTEIN; CRYSTAL-STRUCTURE; HALF-LIFE; GAMMA-GLOBULIN; ANTIBODY FRAGMENTS; BINDING-PROPERTIES; PHARMACOKINETIC PROPERTIES;

D O I：

10.2133/dmpk.24.318

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

The half-life of the two most abundant proteins in blood, immunoglobulin G (IgG) and serum albumin, is extraordinary (similar to 19-23 days) compared to other circulating proteins. This phenomenon secures a broad biodistribution throughout the body of both molecules. The long half-life has made IgG the natural choice for engineering of antibody based therapeutics, while albumin is used as a fusion partner for or carrier of drugs. Remarkably, the half-life of these unrelated proteins has been shown prolonged by a receptor recycling pathway mediated by a common cell bound receptor named the neonatal Fc receptor (FcRn). This review summarizes our current understanding of FcRn function and discusses its relevance for development of new IgG and albumin based therapeutics and diagnostics.

引用

收藏

页码：318 / 332

页数：15

相关论文

共 161 条

[1]

The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease [J].

Akilesh, S ;

Petkova, S ;

Sproule, TJ ;

Shaffer, DJ ;

Christianson, GJ ;

Roopenian, D .

JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) :1328-1333

[2]

Podocytes use FcRn to clear IgG from the glomerular basement membrane [J].

Akilesh, Shreeram ;

Huber, Tobias B. ;

Wu, Hui ;

Wang, Gary ;

Hartleben, Bjoern ;

Kopp, Jeffrey B. ;

Miner, Jeffrey H. ;

Roopenian, Derry C. ;

Unanue, Emil R. ;

Shaw, Andrey S. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (03) :967-972

[3]

Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism [J].

Akilesh, Shreeram ;

Christianson, Gregory J. ;

Roopenian, Derry C. ;

Shaw, Andrey S. .

JOURNAL OF IMMUNOLOGY, 2007, 179 (07) :4580-4588

[4]

Purification, properties and extended solution structure of the complex formed between human immunoglobulin A1 and human serum albumin by scattering and ultracentrifugation [J].

Almogren, A ;

Furtado, PB ;

Sun, Z ;

Perkins, SJ ;

Kerr, MA .

JOURNAL OF MOLECULAR BIOLOGY, 2006, 356 (02) :413-431

[5]

Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues [J].

Andersen, Jan T. ;

Justesen, Sune ;

Fleckenstein, Burkhard ;

Michaelsen, Terje E. ;

Berntzen, Goril ;

Kenanova, Vania E. ;

Daba, Muluneh B. ;

Lauvrak, Vigdis ;

Buus, Soren ;

Sandlie, Inger .

FEBS JOURNAL, 2008, 275 (16) :4097-4110

[6]

A strategy for bacterial production of a soluble functional human neonatal Fc receptor [J].

Andersen, Jan Terje ;

Justesen, Sune ;

Berntzen, Goril ;

Michaelsen, Terje E. ;

Lauvrak, Vigdis ;

Fleckenstein, Burkhard ;

Buus, Soren ;

Sandlie, Inger .

JOURNAL OF IMMUNOLOGICAL METHODS, 2008, 331 (1-2) :39-49

[7]

A receptor-mediated mechanism to support clinical observation of altered albumin variants [J].

Andersen, Jan Terje ;

Sandlie, Inger .

CLINICAL CHEMISTRY, 2007, 53 (12) :2216-2216

[8]

The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin [J].

Andersen, Jan Terje ;

Qian, Julie Dee ;

Sandlie, Inger .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (11) :3044-3051

[9]

Identification of a receptor required for the anti-inflammatory activity of IVIG [J].

Anthony, Robert M. ;

Wermeling, Fredrik ;

Karlsson, Mikael C. I. ;

Ravetch, Jeffrey V. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (50) :19571-19578

[10]

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients [J].

Bain, VG ;

Kaita, KD ;

Yoshida, EM ;

Swain, MG ;

Heathcote, EJ ;

Neumann, AU ;

Fiscella, M ;

Yu, R ;

Osborn, BL ;

Cronin, PW ;

Freimuth, WW ;

McHutchison, JG ;

Subramanian, GM .

JOURNAL OF HEPATOLOGY, 2006, 44 (04) :671-678

← 1 2 3 4 5 6 7 8 9 10 →